Insulet (PODD) –
-
Form DEFA14A INSULET CORP
-
Form DEF 14A INSULET CORP For: May 22
-
Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
-
Canaccord Genuity Likes Insulet Corporation (PODD) Management Appointment
-
Insulet (PODD) Mention Cautiously by Short Seller
-
Form 8-K INSULET CORP For: Mar 20
-
Insulet (PODD) Appoints Ana Maria Chadwick as CFO
-
Insulet Appoints Ana Maria Chadwick as Chief Financial Officer
-
Insulet's (PODD) Trial Demonstrates Omnipod 5 Automated Insulin Delivery System is Superior to Pump Therapy
-
Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy
-
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
-
Form 8-K INSULET CORP For: Feb 26
-
Form 4 INSULET CORP For: Feb 28 Filed by: Petrovic Shacey
-
Form 4 INSULET CORP For: Feb 27 Filed by: Singh Prem
-
Form 4 INSULET CORP For: Feb 27 Filed by: Kapples John W.
-
Form 4 INSULET CORP For: Feb 27 Filed by: Manea Dan
-
Form 4 INSULET CORP For: Feb 27 Filed by: Field Mark N
-
Form 4 INSULET CORP For: Feb 27 Filed by: Hollingshead James
-
Form 4 INSULET CORP For: Feb 27 Filed by: Cousin Laetitia
-
Form 4 INSULET CORP For: Feb 27 Filed by: Budden Lauren
-
Form 4 INSULET CORP For: Feb 27 Filed by: Benjamin Eric
-
Form 144 INSULET CORP Filed by: Petrovic Shacey
-
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.16%
-
Insulet Corporation (PODD) PT Lowered to $213 at Barclays
-
Insulet Corporation (PODD) PT Raised to $225 at JPMorgan
-
Insulet Corporation (PODD) PT Lowered to $230 at Piper Sandler
-
Form 10-K INSULET CORP For: Dec 31
-
After-hours movers: Shares of Carvana (CVNA) and Block (SQ) surge
-
Insulet (PODD) Tops Q4 EPS by 75c, offers guidance
-
Insulet posts better-than-expected quarterly results
-
Form 8-K INSULET CORP For: Feb 22
-
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency¹) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
-
Form 4 INSULET CORP For: Feb 20 Filed by: Manea Dan
-
Form 4 INSULET CORP For: Feb 20 Filed by: Kapples John W.
-
Form 4 INSULET CORP For: Feb 20 Filed by: Field Mark N
-
Form 4 INSULET CORP For: Feb 20 Filed by: Budden Lauren
-
Form 4 INSULET CORP For: Feb 20 Filed by: Benjamin Eric
-
Form SC 13G/A INSULET CORP Filed by: VANGUARD GROUP INC
-
Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
-
Form SC 13G/A INSULET CORP Filed by: Capital World Investors
-
Form SC 13G/A INSULET CORP Filed by: Capital Research Global Investors
-
Form SC 13G/A INSULET CORP Filed by: FMR LLC
-
Form SC 13G/A INSULET CORP Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Insulet (PODD) Announces CE Mark Approval of Omnipod 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
-
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
-
Insulet Corporation (PODD) PT Raised to $208 at Stifel
-
Imperative Care Announces Four Senior Leadership Appointments
-
Form SC 13G/A INSULET CORP Filed by: BlackRock Inc.
-
Form 8-K INSULET CORP For: Jan 24
-
Form 4 INSULET CORP For: Jan 18 Filed by: STONESIFER TIMOTHY C.
Back to PODD Stock Lookup